Open access
Open access
Powered by Google Translator Translator

Archives

Study | Left ventricular dysfunction in brain-dead heart donors – incidence, reversibility, and implications

31 Jul, 2023 | 14:09h | UTC

Left Ventricular Dysfunction Associated With Brain Death: Results From the Donor Heart Study – Circulation (free for a limited period)

 


Review | Antiamyloid monoclonal antibody therapy for Alzheimer disease: emerging issues in neurology

31 Jul, 2023 | 14:07h | UTC

Antiamyloid Monoclonal Antibody Therapy for Alzheimer Disease: Emerging Issues in Neurology – Neurology

News Release: AAN issues guidance on new treatments for early Alzheimer’s disease – American Academy of Neurology

 


M-A | Cardiovascular events in patients treated with bempedoic acid versus placebo

31 Jul, 2023 | 14:06h | UTC

Cardiovascular events in patients treated with bempedoic acid versus placebo: systematic review and meta-analysis – European Heart Journal – Cardiovascular Pharmacotherapy

 

Commentary on Twitter

 


Study | Childhood deaths in high-mortality settings mostly preventable; infection, malnutrition top causes

31 Jul, 2023 | 14:05h | UTC

Causes of Death Among Infants and Children in the Child Health and Mortality Prevention Surveillance (CHAMPS) Network – JAMA Network Open

Invited Commentary: Need for a Structural Approach to Promote Child Survival – JAMA Network Open

News Release: Eight out of ten child deaths in low-income countries could be prevented – Barcelona Institute for Global Health

 


Review | Regional analgesia for acute pain relief after open thoracotomy and video-assisted thoracoscopic surgery

31 Jul, 2023 | 14:03h | UTC

Regional analgesia for acute pain relief after open thoracotomy and video-assisted thoracoscopic surgery – BJA Education

 


Review | Perioperative iron deficiency anemia

31 Jul, 2023 | 14:02h | UTC

Perioperative iron deficiency anaemia – BJA Education

 


RCT | Bictegravir regimen noninferior to dolutegravir regimen in HIV-1, HBV co-infection treatment

31 Jul, 2023 | 14:00h | UTC

Bictegravir, emtricitabine, and tenofovir alafenamide versus dolutegravir, emtricitabine, and tenofovir disoproxil fumarate for initial treatment of HIV-1 and hepatitis B coinfection (ALLIANCE): a double-blind, multicentre, randomised controlled, phase 3 non-inferiority trial – The Lancet HIV (free registration required)

 


RCT | Niraparib after first-line platinum-based chemotherapy extends PFS vs. placebo in newly diagnosed advanced ovarian cancer

31 Jul, 2023 | 13:58h | UTC

Treatment With Niraparib Maintenance Therapy in Patients With Newly Diagnosed Advanced Ovarian Cancer: A Phase 3 Randomized Clinical Trial – JAMA Oncology

See also: Visual Abstract

Commentary: Niraparib Maintenance in Newly Diagnosed Advanced Ovarian Cancer – The ASCO Post

 


Systematic Review | Organizational changes likely decrease physical restraint usage in long-term care

31 Jul, 2023 | 13:53h | UTC

Interventions for preventing and reducing the use of physical restraints for older people in all long‐term care settings – Cochrane Library

Summary: Interventions for preventing and reducing the use of physical restraints in all long-term care settings – Cochrane Library

 


Systematic Review | Probiotics’ potential in preventing necrotizing enterocolitis in very preterm, VLBW infants warrants further research

31 Jul, 2023 | 13:51h | UTC

Probiotics to prevent necrotising enterocolitis in very preterm or very low birth weight infants – Cochrane Library

 


RCT | Combined endovenous ablation and compression speeds up venous leg ulcers healing

31 Jul, 2023 | 13:49h | UTC

Endovenous ablation for venous leg ulcers – Cochrane Library

Summary: What are the benefits and risks of endovenous ablation (using heat or medication to permanently close veins) for treating venous leg ulcers – Cochrane Library

 


Registry Analysis | Similar 1-year mortality rates post-TAVR in cardiogenic shock patients surviving 30-day mark

31 Jul, 2023 | 13:47h | UTC

Outcomes of transcatheter aortic valve replacement in patients with cardiogenic shock – European Heart Journal

Commentary: TAVR Found Safe and Effective in Patients With Cardiogenic Shock: An NCDR Analysis – American College of Cardiology

 

Commentary on Twitter

 


UNESCO calls for global ban on smartphones in schools

28 Jul, 2023 | 14:26h | UTC

Report: Technology in education – UNESCO

News Releases:

UNESCO calls for global ban on smartphones in schools – UN News

Smartphones in school? Only when they clearly support learning – UNESCO

Commentary: ‘Put learners first’: Unesco calls for global ban on smartphones in schools – The Guardian

 


WHO updates guidelines on fats and carbohydrates

28 Jul, 2023 | 14:25h | UTC

News Release: WHO updates guidelines on fats and carbohydrates – World Health Organization

Guidelines:

Saturated fatty acid and trans-fatty acid intake for adults and children: WHO guideline – World Health Organization

Total fat intake for the prevention of unhealthy weight gain in adults and children: WHO guideline – World Health Organization

Carbohydrate intake for adults and children: WHO guideline – World Health Organization

 

Commentary on Twitter (thread – click for more)

 


New WHO lists of essential medicines

28 Jul, 2023 | 14:23h | UTC

News Release: WHO endorses landmark public health decisions on Essential Medicines for Multiple Sclerosis – World Health Organization

Lists of Essential Medicines

Model Lists of Essential Medicines – World Health Organization

Model Lists of Essential Medicines for Children – World Health Organization

 

Commentary on Twitter

 


Study | Only 11% of sports supplements listing botanical ingredients accurately declare contents, 12% contain FDA-prohibited stimulants

28 Jul, 2023 | 14:21h | UTC

Presence and Quantity of Botanical Ingredients With Purported Performance-Enhancing Properties in Sports Supplements – JAMA Network Open

Commentaries:

Ensuring the Safety and Value of Supplements – JAMA Network Open

Sports Supplements Can Be Contaminated with Botanical Stimulants and Anabolic Agents – NEJM Journal Watch

 


BMJ Investigation | Medical royal colleges receive millions from drug and medical devices companies

28 Jul, 2023 | 14:19h | UTC

Medical royal colleges receive millions from drug and medical devices companies – The BMJ

News Release: Medical royal colleges receive millions from drug/medical device companies – BMJ Newsroom

 

Commentary on Twitter

 


JAMA guidance for authors, peer reviewers, and editors on use of AI, language models, and chatbots

28 Jul, 2023 | 14:18h | UTC

Guidance for Authors, Peer Reviewers, and Editors on Use of AI, Language Models, and Chatbots – JAMA

See also, just published: New recommendations of the International Committee of Medical Journal Editors: use of artificial intelligence – European Heart Journal

Related

Comparing scientific abstracts generated by ChatGPT to real abstracts with detectors and blinded human reviewers – npj Digital Medicine

ChatGPT et al? Not So Fast, Say Journal Editors – TCTMD

Chat GPT will change Medicine – Vinay Prasad’s Observations and Thoughts

ChatGPT has many uses. Experts explore what this means for healthcare and medical research – The Conversation

Can artificial intelligence help for scientific writing? – Critical Care

Artificial intelligence in academic writing: a paradigm-shifting technological advance

Perspective | Generating scholarly content with ChatGPT: ethical challenges for medical publishing

ChatGPT and the future of medical writing (ChatGPT itself wrote this paper)

Nonhuman “Authors” and Implications for the Integrity of Scientific Publication and Medical Knowledge – JAMA

ChatGPT is fun, but not an author – Science

Tools such as ChatGPT threaten transparent science; here are our ground rules for their use – Nature

ChatGPT listed as author on research papers: many scientists disapprove – Nature

Abstracts written by ChatGPT fool scientists

 


Study | New deep learning model effectively detects type 2 diabetes from chest X-rays

28 Jul, 2023 | 14:15h | UTC

Opportunistic detection of type 2 diabetes using deep learning from frontal chest radiographs – Nature Communications

 

Commentary on Twitter

 


Position Paper | Prioritizing deprescribing in fall prevention strategies

28 Jul, 2023 | 14:12h | UTC

European position paper on polypharmacy and fall-risk-increasing drugs recommendations in the World Guidelines for Falls Prevention and Management: implications and implementation – European Geriatric Medicine

Original Guideline: World guidelines for falls prevention and management for older adults: a global initiative – Age and Ageing

 


Review | Management of bleeding and hemolysis during percutaneous microaxial flow pump support

28 Jul, 2023 | 14:10h | UTC

Management of Bleeding and Hemolysis During Percutaneous Microaxial Flow Pump Support: A Practical Approach – JACC: Cardiovascular Interventions

 

Commentary on Twitter

 


Phase 2 Trial | Oral orexin receptor 2 agonist shows promise in narcolepsy type 1, but raises hepatotoxic concerns

28 Jul, 2023 | 14:09h | UTC

Oral Orexin Receptor 2 Agonist in Narcolepsy Type 1 – New England Journal of Medicine (link to abstract – $ for full-text)

 

Commentary on Twitter

 


Cohort Study | Exploring the potential impact of artificial sweeteners on type 2 diabetes risk

28 Jul, 2023 | 14:07h | UTC

Artificial Sweeteners and Risk of Type 2 Diabetes in the Prospective NutriNet-Santé Cohort – Diabetes Care

 


RCT | Liraglutide aids weight management in patients with suboptimal weight loss post metabolic surgery

28 Jul, 2023 | 14:05h | UTC

Safety and Efficacy of Liraglutide, 3.0 mg, Once Daily vs Placebo in Patients With Poor Weight Loss Following Metabolic Surgery: The BARI-OPTIMISE Randomized Clinical Trial – JAMA Surgery

See also: Visual Abstract

 


A new global definition of Acute Respiratory Distress Syndrome

27 Jul, 2023 | 13:14h | UTC

A New Global Definition of Acute Respiratory Distress Syndrome – American Journal of Respiratory and Critical Care Medicine

 

Commentary on Twitter

 


Stay Updated in Your Specialty

Telegram Channels
Free

WhatsApp alerts 10-day free trial

No spam, just news.